Sym Financial Corporation »

Alnylam Pharmaceuticals shares owned by Sym Financial Corporation

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Sym Financial Corporation from 13F filings

Historical chart of Sym Financial Corporation investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Sym Financial Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Sym Financial Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $308k 675 456.00
2025-06-30 $308k 944 326.09
2025-03-31 $274k 1.0k 270.02
2024-12-31 $227k 963 235.31
2024-06-30 $217k 892 243.00

More positions owned by Sym Financial Corporation

Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Wisdomtree Tr Internationl Efi (NTSI)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Us Treas Bd Etf (GOVT)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Dow (DOW)
Apple (AAPL)
Vanguard Admiral Fds Smlcp 600 Val (VIOV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for Sym Financial Corporation

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals